277 related articles for article (PubMed ID: 28814801)
1. Strain-dependence of the Angelman Syndrome phenotypes in Ube3a maternal deficiency mice.
Born HA; Dao AT; Levine AT; Lee WL; Mehta NM; Mehra S; Weeber EJ; Anderson AE
Sci Rep; 2017 Aug; 7(1):8451. PubMed ID: 28814801
[TBL] [Abstract][Full Text] [Related]
2. Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome.
Copping NA; Silverman JL
Mol Autism; 2021 Feb; 12(1):9. PubMed ID: 33549123
[TBL] [Abstract][Full Text] [Related]
3. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
Jiang YH; Pan Y; Zhu L; Landa L; Yoo J; Spencer C; Lorenzo I; Brilliant M; Noebels J; Beaudet AL
PLoS One; 2010 Aug; 5(8):e12278. PubMed ID: 20808828
[TBL] [Abstract][Full Text] [Related]
4. Early Developmental EEG and Seizure Phenotypes in a Full Gene Deletion of Ubiquitin Protein Ligase E3A Rat Model of Angelman Syndrome.
Born HA; Martinez LA; Levine AT; Harris SE; Mehra S; Lee WL; Dindot SV; Nash KR; Silverman JL; Segal DJ; Weeber EJ; Anderson AE
eNeuro; 2021; 8(2):. PubMed ID: 33531368
[TBL] [Abstract][Full Text] [Related]
5. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome.
Colas D; Wagstaff J; Fort P; Salvert D; Sarda N
Neurobiol Dis; 2005 Nov; 20(2):471-8. PubMed ID: 15921919
[TBL] [Abstract][Full Text] [Related]
6. Behavioral deficits in an Angelman syndrome model: effects of genetic background and age.
Huang HS; Burns AJ; Nonneman RJ; Baker LK; Riddick NV; Nikolova VD; Riday TT; Yashiro K; Philpot BD; Moy SS
Behav Brain Res; 2013 Apr; 243():79-90. PubMed ID: 23295389
[TBL] [Abstract][Full Text] [Related]
7. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice.
Miura K; Kishino T; Li E; Webber H; Dikkes P; Holmes GL; Wagstaff J
Neurobiol Dis; 2002 Mar; 9(2):149-59. PubMed ID: 11895368
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Nociception in Angelman Syndrome Model Mice.
McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
[TBL] [Abstract][Full Text] [Related]
9. GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.
Judson MC; Wallace ML; Sidorov MS; Burette AC; Gu B; van Woerden GM; King IF; Han JE; Zylka MJ; Elgersma Y; Weinberg RJ; Philpot BD
Neuron; 2016 Apr; 90(1):56-69. PubMed ID: 27021170
[TBL] [Abstract][Full Text] [Related]
10. Seizure-like activity in a juvenile Angelman syndrome mouse model is attenuated by reducing Arc expression.
Mandel-Brehm C; Salogiannis J; Dhamne SC; Rotenberg A; Greenberg ME
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5129-34. PubMed ID: 25848016
[TBL] [Abstract][Full Text] [Related]
11. A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel
Sonzogni M; Wallaard I; Santos SS; Kingma J; du Mee D; van Woerden GM; Elgersma Y
Mol Autism; 2018; 9():47. PubMed ID: 30220990
[TBL] [Abstract][Full Text] [Related]
12. Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice.
Gu B; Carstens KE; Judson MC; Dalton KA; Rougié M; Clark EP; Dudek SM; Philpot BD
J Clin Invest; 2019 Jan; 129(1):163-168. PubMed ID: 30352049
[TBL] [Abstract][Full Text] [Related]
13. Of mothers and myelin: Aberrant myelination phenotypes in mouse model of Angelman syndrome are dependent on maternal and dietary influences.
Grier MD; Carson RP; Lagrange AH
Behav Brain Res; 2015 Sep; 291():260-267. PubMed ID: 26028516
[TBL] [Abstract][Full Text] [Related]
14. Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes.
Sonzogni M; Hakonen J; Bernabé Kleijn M; Silva-Santos S; Judson MC; Philpot BD; van Woerden GM; Elgersma Y
Mol Autism; 2019; 10():23. PubMed ID: 31143434
[TBL] [Abstract][Full Text] [Related]
15.
Wallace ML; van Woerden GM; Elgersma Y; Smith SL; Philpot BD
J Neurophysiol; 2017 Jul; 118(1):634-646. PubMed ID: 28468997
[TBL] [Abstract][Full Text] [Related]
16. Hypersociability in the Angelman syndrome mouse model.
Stoppel DC; Anderson MP
Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
[TBL] [Abstract][Full Text] [Related]
17. Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome.
Mardirossian S; Rampon C; Salvert D; Fort P; Sarda N
Exp Neurol; 2009 Dec; 220(2):341-8. PubMed ID: 19782683
[TBL] [Abstract][Full Text] [Related]
18. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome.
DeLorey TM; Handforth A; Anagnostaras SG; Homanics GE; Minassian BA; Asatourian A; Fanselow MS; Delgado-Escueta A; Ellison GD; Olsen RW
J Neurosci; 1998 Oct; 18(20):8505-14. PubMed ID: 9763493
[TBL] [Abstract][Full Text] [Related]
19. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
Mulherkar SA; Jana NR
Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model.
Chung L; Bey AL; Towers AJ; Cao X; Kim IH; Jiang YH
Neurobiol Dis; 2018 Feb; 110():12-19. PubMed ID: 29097328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
